Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets https://ift.tt/eA8V8J

Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine. Bharat Biotech, which manufactures it, has failed to ramp up production at the pace it had envisaged.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Wr0A1a